Cargando…
Active glycolytic metabolism in CD133(+) hepatocellular cancer stem cells: regulation by MIR-122
Although altered metabolic pathway is an important diagnostic maker and therapeutic target in cancer, it is poorly understood in cancer stem cells (CSCs). Here we show that the CD133 (+) hepatocellular CSCs have distinct metabolic properties, characterized by more active glycolysis over oxidative ph...
Autores principales: | Song, Kyoungsub, Kwon, Hyunjoo, Han, Chang, Zhang, Jinqiang, Dash, Srikanta, Lim, Kyu, Wu, Tong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4747371/ https://www.ncbi.nlm.nih.gov/pubmed/26506419 |
Ejemplares similares
-
Hepatic Stress Response in HCV Infection Promotes STAT3-Mediated Inhibition of HNF4A-miR-122 Feedback Loop in Liver Fibrosis and Cancer Progression
por: Aydin, Yucel, et al.
Publicado: (2019) -
Mir-1, miR-122, miR-132, and miR-133 Are Related to Subclinical Aortic Atherosclerosis Associated with Metabolic Syndrome
por: Šatrauskienė, Agnė, et al.
Publicado: (2021) -
Chromenopyrimidinone Controls Stemness and Malignancy by suppressing CD133 Expression in Hepatocellular Carcinoma
por: Song, Yeonhwa, et al.
Publicado: (2020) -
miR-150 Deficiency Protects against FAS-Induced Acute Liver Injury in Mice through Regulation of AKT
por: Chen, Weina, et al.
Publicado: (2015) -
Gene network analysis reveals a novel 22-gene signature of carbon metabolism in hepatocellular carcinoma
por: Zhang, Jinqiang, et al.
Publicado: (2016)